Quantum Healthcare Limited (SGX:V8Y)

Quantum Healthcare Statistics

Total Valuation

SGXC:V8Y has a market cap or net worth of SGD 12.59 million. The enterprise value is 14.59 million.

Market Cap	12.59M
Enterprise Value	14.59M

Important Dates

The last earnings date was Sunday, March 1, 2026.

Earnings Date	Mar 1, 2026
Ex-Dividend Date	n/a

Share Statistics

SGXC:V8Y has 12.59 billion shares outstanding. The number of shares has increased by 4.30% in one year.

Current Share Class	12.59B
Shares Outstanding	12.59B
Shares Change (YoY)	+4.30%
Shares Change (QoQ)	+3.42%
Owned by Insiders (%)	69.85%
Owned by Institutions (%)	0.27%
Float	3.80B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.96
PB Ratio	-11.95
P/TBV Ratio	n/a
P/FCF Ratio	6.57
P/OCF Ratio	6.40
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.69, with an EV/FCF ratio of 7.61.

EV / Earnings	-5.21
EV / Sales	1.12
EV / EBITDA	9.69
EV / EBIT	n/a
EV / FCF	7.61

Financial Position

The company has a current ratio of 0.54

Current Ratio	0.54
Quick Ratio	0.54
Debt / Equity	n/a
Debt / EBITDA	2.78
Debt / FCF	2.18
Interest Coverage	-0.92

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-1.69%
Return on Invested Capital (ROIC)	-20.77%
Return on Capital Employed (ROCE)	-23.20%
Weighted Average Cost of Capital (WACC)	7.71%
Revenue Per Employee	150,161
Profits Per Employee	-32,161
Employee Count	87
Asset Turnover	1.12
Inventory Turnover	130.86

Taxes

In the past 12 months, SGXC:V8Y has paid 65,000 in taxes.

Income Tax	65,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.71
52-Week Price Change	n/a
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	47.03
Average Volume (20 Days)	1,516,170

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SGXC:V8Y had revenue of SGD 13.06 million and -2.80 million in losses. Loss per share was -0.00.

Revenue	13.06M
Gross Profit	5.93M
Operating Income	-315,000
Pretax Income	-2.85M
Net Income	-2.80M
EBITDA	232,000
EBIT	-315,000
Loss Per Share	-0.00

Balance Sheet

The company has 2.71 million in cash and 4.18 million in debt, with a net cash position of -1.48 million or -0.00 per share.

Cash & Cash Equivalents	2.71M
Total Debt	4.18M
Net Cash	-1.48M
Net Cash Per Share	-0.00
Equity (Book Value)	-1.05M
Book Value Per Share	-0.00
Working Capital	-4.32M

Cash Flow

In the last 12 months, operating cash flow was 1.97 million and capital expenditures -50,000, giving a free cash flow of 1.92 million.

Operating Cash Flow	1.97M
Capital Expenditures	-50,000
Depreciation & Amortization	547,000
Net Borrowing	-2.41M
Free Cash Flow	1.92M
FCF Per Share	0.00

Margins

Gross margin is 45.41%, with operating and profit margins of -2.41% and -21.42%.

Gross Margin	45.41%
Operating Margin	-2.41%
Pretax Margin	-21.80%
Profit Margin	-21.42%
EBITDA Margin	1.78%
EBIT Margin	-2.41%
FCF Margin	14.67%

Dividends & Yields

SGXC:V8Y does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.30%
Shareholder Yield	-4.30%
Earnings Yield	-22.23%
FCF Yield	15.22%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SGXC:V8Y has an Altman Z-Score of -31.84 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-31.84
Piotroski F-Score	6